Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.2 USD | -0.73% | +2.62% | -21.00% |
May. 02 | Alnylam Pharmaceuticals' Q1 Non-GAAP Net Loss Narrows as Revenue Increases; 2024 Outlook Affirmed | MT |
May. 02 | Transcript : Alnylam Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.